NCT07242547
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07242547
Title Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients (MERLIN)
Acronym MERLIN
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fundacion GECP
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP


No variant requirements are available.